Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of tre...
Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients: a referral center study
About this item
Full title
Author / Creator
Safarnezhad Tameshkel, Fahimeh , Karbalaie Niya, Mohammad Hadi , Zamani, Farhad , Motamed, Nima , Ajdarkosh, Hossein , Vafaeimanesh, Jamshid , Khoonsari, Mahmoodreza , Sohrabi, Masood Reza , Aten, Sima , Azarkeivan, Azita , Eslami, Masoumeh Sadat , Perumal, Dhayaneethie , Maadi, Mansooreh , Ghanbari, Behrooz and Keyvani, Hossein
Publisher
Vienna: Springer Vienna
Journal title
Language
English
Formats
Publication information
Publisher
Vienna: Springer Vienna
Subjects
More information
Scope and Contents
Contents
Patients with thalassemia major are at high risk of hepatitis C through blood transfusion from donors infected by hepatitis C virus (HCV). The use of direct-acting antiviral (DAA) therapy against such HCV infections has increased in different populations. However, resistant viral variants can affect treatment outcomes, and therefore improved survei...
Alternative Titles
Full title
Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients: a referral center study
Authors, Artists and Contributors
Author / Creator
Karbalaie Niya, Mohammad Hadi
Zamani, Farhad
Motamed, Nima
Ajdarkosh, Hossein
Vafaeimanesh, Jamshid
Khoonsari, Mahmoodreza
Sohrabi, Masood Reza
Aten, Sima
Azarkeivan, Azita
Eslami, Masoumeh Sadat
Perumal, Dhayaneethie
Maadi, Mansooreh
Ghanbari, Behrooz
Keyvani, Hossein
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2421463795
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2421463795
Other Identifiers
ISSN
0304-8608
E-ISSN
1432-8798
DOI
10.1007/s00705-020-04728-x
